India’s startup and business ecosystem saw a mix of high-value funding deals, strategic investments, and notable corporate developments on 11 August 2025. From multi-million-dollar raises in AI, biotech, and e-commerce to IPO market activity, EV infrastructure expansion, and regulatory updates, here’s your quick roundup for the top funding deals and key business highlights in India today.
Daily Indian Funding Digest – 11 August 2025
| Company | Round / Type | Amount (local / USD) | Lead investor(s) | Sector |
|---|---|---|---|---|
| Graas.ai | Pre-Series B | $9.0 million | Tin Men Capital (lead) | Commerce / AI |
| Eyestem Research (Eyecyte-RPE™) | Oversubscribed funding round | $10.0 million | Existing + strategic investors (not fully named) | Clinical-stage biotech / cell therapy |
| Truemeds | Series C (closed in two tranches) | $85.0 million | Accel; Peak XV Partners | E-pharmacy / telehealth |
| Neuralzome Cybernetic | Pre-seed | $2.4 million | 8X Ventures (lead) | Deeptech robotics / autonomy |
| FincFriends | Debt funding (tranche) | Rs 41.5 crore (debt) | Existing lenders (IBL Finance, Moneywise, others) | NBFC / digital lending |
| Limelight Lab Grown Diamonds | Strategic investment / ambassador appointment | Undisclosed (Shilpa Shetty invested) | Shilpa Shetty (strategic investor & brand ambassador) | Jewellery / lab-grown diamonds |
Graas.ai – $9.0M pre-Series B for agentic commerce growth
Graas.ai, an AI-native commerce data and automation firm, raised over $9 million in a pre-Series B round led by Tin Men Capital, with participation from Incred Wealth, Orzon and existing backers including Integra Partners and Yuj Ventures. The company says the capital will accelerate its Agent Foundry product and regional expansion across India and Southeast Asia.
Eyestem Research – $10.0M to advance Eyecyte-RPE™ (Phase 2 / US IND prep)
Clinical-stage biotechnology company Eyestem Research Pvt Ltd secured an oversubscribed funding round totalling $10 million to complete its ongoing Phase 2 trial for Eyecyte-RPE™ in India and to prepare for a US FDA IND filing. Company statements highlighted promising Phase 1 safety and early efficacy signals and said proceeds will support trial completion and regulatory readiness.
Truemeds – $85.0M Series C (closed in two tranches)
Mumbai-based e-pharmacy and telehealth platform Truemeds has closed a $85 million Series C, led by Accel and Peak XV Partners; the round was completed in two tranches and included participation from WestBridge Capital and Info Edge Ventures. The company plans to expand fulfilment centres in non-metro areas, scale product and engineering teams, and roll out diagnostics services and an iOS app. Financial context reported: Truemeds doubled revenue to INR 315 crore in FY24 while narrowing losses.
Neuralzome Cybernetic – $2.4M pre-seed to build no-code teachable agents for robots
Bengaluru-based deeptech startup Neuralzome Cybernetic raised $2.4 million in a pre-seed round led by 8X Ventures, with participation from Turbostart, Avinya Ventures, Saka Ventures, Appreciate Capital, Astir Ventures, IIM-Ahmedabad’s CIIE, SIDBI and Heston Castelino. The funds will support R&D in multi-agent autonomy, vision-based navigation, manufacturing scale-up and expansion to North America and Europe. The company follows a Robot-as-a-Service model.
FincFriends – INR 41.5 Cr debt facility to grow lending in smaller towns
RBI-registered NBFC FincFriends raised INR 41.5 crore of debt from existing investors (including IBL Finance, Moneywise Financial Services, Usha Financial Services, Shine Star Build Cap, Realtouch Finance and UC Inclusive Credit) in Q1 of FY26. The company said the capital will be used to scale lending through its RupeeRedee platform, focusing on Tier-II and Tier-III markets.
Limelight Lab Grown Diamonds – Shilpa Shetty onboarded as investor & brand ambassador
Mumbai-based jeweller Limelight Lab Grown Diamonds announced that actor-entrepreneur Shilpa Shetty has joined as a strategic investor and brand ambassador. Limelight currently operates over 50 stores across more than 45 Indian cities and intends to scale to 100 stores by 2026. Earlier fundraising in February 2025 saw nearly $11 million (INR 90 crore) raised; this recent Shilpa Shetty investment was not disclosed in monetary terms.
Key News Highlights for 11 August 2025
BlueStone Jewellery IPO Sees Strong Debut with QIB Demand
The initial public offering (IPO) of BlueStone Jewellery opened on a positive note, achieving 39% subscription on its first day. Qualified Institutional Buyers (QIBs) led the charge with 57% subscription, followed by retail investors at 38% and non-institutional investors at 4%. The employee quota saw no bids on day one. The IPO, open from 11 to 13 August 2025, is priced between ₹492 and ₹517 per share. Strong institutional demand suggests confidence in the company’s growth prospects.
Tesla Expands Supercharger Network in Key Indian Cities
Tesla is accelerating its charging infrastructure rollout in Delhi–NCR, Mumbai, and Bengaluru ahead of its scheduled vehicle deliveries in September 2025. New Supercharging stations are planned in locations such as Gurugram, Saket, Noida, Lower Parel, Navi Mumbai, and Thane. The initiative follows the recent opening of Tesla’s second experience centre in Delhi Aerocity and is aimed at ensuring early adopters have reliable charging access.
CCI Seeks Additional Evidence in Quick-Commerce Antitrust Review
The Competition Commission of India (CCI) has requested more details from the petitioner in its initial review of alleged anti-competitive practices by quick-commerce players Blinkit, Instamart, and Zepto. The case is currently in the evidence-gathering stage, and no formal investigation has been launched yet. The request for further documentation indicates that the regulator is assessing whether the matter warrants a deeper probe into potential market dominance issues.







